title: Cadmium-induced alterations in blood-brain barrier permeability and its possible correlation with decreased microvessel antioxidant potential in rat.
abstract: 1. Male albino rats of 21 days age were exposed to 10 p.p.m. cadmium (CdCl2 salt) in drinking water, ad libitum, for 90 days. It increased the brain cadmium levels by 76% (P < 0.05) and 165% (P < 0.001) respectively at 30 and 90 days of exposure compared to controls. 2. Cadmium increased blood-brain barrier permeability of fluoroscein dye (24%, P < 0.02) and the levels of brain microvessel malondialdehyde (31%, P < 0.01) at 90 days of exposure. However, these parameters did not alter significantly at 30 days of exposure. 3. Increased activities of microvessel superoxide dismutase (18%, P < 0.02), glutathione peroxidase (20%, P < 0.01) and catalase (28%, P < 0.01) were observed at 30 days of exposure. 4. The continuation of the Cd treatment for 90 days decreased the levels of superoxide dismutase (30%, P < 0.001), glutathione peroxidase (23%, P < 0.005), catalase (25%, P < 0.005), glutathione reductase (18%, P < 0.02), vitamin E (20%, P < 0.01), glutathione (26%, P < 0.01), ascorbic acid (18%, P < 0.05) and ceruloplasmin (13%, P < 0.05) in the microvessal preparation compared to controls. 5. It appears that Cd-induced blood-brain barrier dysfunction may be related to the depletion of microvessel antioxidant substances along with increase in lipid peroxidation at 90 days of exposure.
authors: Industrial Toxicology Research Centre, Central Drug Research Institute, Lucknow, India.
authors: A
authors: A
authors: Shukla
authors: G S
authors: GS
authors: Shukla
authors: R C
authors: RC
authors: Srimal
mesh_terms: D000284:Administration, Oral; D000818:Animals; D001205:Ascorbic Acid / Q000097:blood; D001812:Blood-Brain Barrier / Q000187:drug effects*; D001921:Brain / Q000378:metabolism; D002104:Cadmium / Q000097:blood / Q000378:metabolism*; D019256:Cadmium Chloride / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000633:toxicity*; D002199:Capillary Permeability / Q000187:drug effects*; D002374:Catalase / Q000097:blood / Q000378:metabolism; D002570:Ceruloplasmin / Q000378:metabolism; D019793:Fluorescein; D005452:Fluoresceins / Q000493:pharmacokinetics; D005978:Glutathione / Q000378:metabolism; D005979:Glutathione Peroxidase / Q000097:blood / Q000378:metabolism; D005980:Glutathione Reductase / Q000097:blood / Q000378:metabolism; D015227:Lipid Peroxidation / Q000187:drug effects; D008297:Male; D008315:Malondialdehyde / Q000378:metabolism; D018384:Oxidative Stress; D011897:Random Allocation; D051381:Rats; D013482:Superoxide Dismutase / Q000097:blood / Q000378:metabolism; D014810:Vitamin E / Q000097:blood
chemical_list: D005452:Fluoresceins; D002104:Cadmium; D014810:Vitamin E; D008315:Malondialdehyde; D002374:Catalase; D005979:Glutathione Peroxidase; D013482:Superoxide Dismutase; D002570:Ceruloplasmin; D005980:Glutathione Reductase; D005978:Glutathione; D019256:Cadmium Chloride; D001205:Ascorbic Acid; D019793:Fluorescein